HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--April 28, 2006--Three independent analyst reports have "buy" recommendations for Nymox Pharmaceutical Corporation (NASDAQ: NYMX - News). These include: Dutton Associates (written by Dr. William Prather on March 15, 2006), WallStreet Research (written by Alan Stone on December 22, 2005), and Cohen Independent Research Group (written on December 6, 2005).
